Ovid Therapeutics Inc (OVID)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -30,697 | -16,108 | 122,835 | 148,835 | 160,219 |
| Depreciation Amortization | 526 | 74 | 237 | 180 | 128 |
| Accounts receivable | N/A | N/A | 142 | 142 | 142 |
| Accounts payable and accrued liabilities | -2,511 | -4,870 | 1,703 | -2,284 | -4,518 |
| Other Working Capital | -5,798 | -4,313 | -16,815 | -22,144 | -21,442 |
| Other Operating Activity | 5,104 | 5,131 | 10,510 | 5,881 | 6,954 |
| Operating Cash Flow | $-33,375 | $-20,086 | $118,612 | $130,610 | $141,482 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -80,416 | -1,000 | N/A | N/A | N/A |
| PPE Investments | -1,086 | -46 | -184 | -22 | N/A |
| Purchase Of Investment | N/A | N/A | -1,632 | -1,632 | -1,584 |
| Purchase Sale Intangibles | -251 | -30 | -5 | -5 | -12 |
| Other Investing Activity | -251 | -30 | -5 | -5 | -12 |
| Investing Cash Flow | $-81,753 | $-1,076 | $-1,821 | $-1,659 | $-1,595 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 143 | 33 | 925 | 816 | 267 |
| Other Financing Activity | 0 | 0 | -21 | -21 | -21 |
| Financing Cash Flow | $143 | $33 | $904 | $795 | $246 |
| Beginning Cash Position | 189,728 | 189,728 | 72,034 | 72,034 | 72,034 |
| End Cash Position | 74,743 | 168,599 | 189,728 | 201,780 | 212,167 |
| Net Cash Flow | $-114,986 | $-21,130 | $117,694 | $129,746 | $140,133 |
| Free Cash Flow | |||||
| Operating Cash Flow | -33,375 | -20,086 | 118,612 | 130,610 | 141,482 |
| Capital Expenditure | -1,086 | -46 | -184 | -22 | 0 |
| Free Cash Flow | -34,461 | -20,132 | 118,428 | 130,588 | 141,482 |